| Emily Gnip, RPH | |
|
530 N Kenwood St, Suite 308, Glendale, CA 91206-3263 | |
| (928) 763-6822 | |
| (928) 763-6817 |
| Full Name | Emily Gnip |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 530 N Kenwood St, Glendale, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295148005 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | S015243 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Emily Gnip, RPH 530 N Kenwood St, Suite 308, Glendale, CA 91206-3263 Ph: (928) 763-6822 | Emily Gnip, RPH 530 N Kenwood St, Suite 308, Glendale, CA 91206-3263 Ph: (928) 763-6822 |
News Archive
Researchers have discovered new insights into how one of the two X-chromosomes is silenced during the development of female human embryos and also in lab-grown stem cells.
Diabetes is a significant global health problem, afflicting 382 million people worldwide with increasing prevalence rates and adverse effects on health, wellbeing, and society in general. In this special issue of the Annals of Global Health, "Global Dimensions of Diabetes Care," experts from around the world synthesize a core set of recommendations using information from 14 countries as a basis in order to work towards optimizing diabetes care globally - a critically important initiative to help stem the diabetes epidemic.
An innovative mechanism that the innate immune system uses to control viral infections has been uncovered by researchers at the University Medical Centers in Mainz and Freiburg. Central to this is the discovery that two different but related elements of the immune system can act together in concert to fight, for example, rotavirus infections.
A shortened version of a questionnaire used by psychologists to assess risk factors for obsessive-compulsive disorder also may help determine the risk of depression and anxiety, according to a Baylor University study.
Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its new molecular amplification assay, illumigene™ C. difficile. Clostridium difficile is a bacterium that can cause diarrhea and, in severe cases, a life-threatening inflammation of the colon.
› Verified 8 days ago
Rosemary Kahale, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 125 N Central Ave, Glendale, CA 91203 Phone: 818-637-2758 | |
Annie Ahhyun Kim, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3943 San Fernando Rd, Glendale, CA 91204 Phone: 818-549-2270 | |
Dr. Linda Kalamkeryan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 W Stocker St, 105, Glendale, CA 91202 Phone: 818-433-8379 | |
Dr. Jane Kyun Lee, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1509 Wilson Ter, Glendale, CA 91206 Phone: 818-409-8000 | |
Anna Arutunyan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1122 E Broadway, Glendale, CA 91205 Phone: 818-547-0170 | |
Dr. Monica Natalia Macias, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1509 Wilson Terrace, Glendale, CA 91206 Phone: 818-409-8140 | |
Arash Akmal, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3452 Country Club Dr, Glendale, CA 91208 Phone: 310-463-7326 |